MARKET

IBIO

IBIO

Ibio
NASDAQ
1.670
+0.080
+5.03%
After Hours: 1.665 -0.005 -0.31% 19:58 06/26 EDT
OPEN
1.600
PREV CLOSE
1.590
HIGH
1.680
LOW
1.570
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
3.820
52 WEEK LOW
0.5562
MARKET CAP
82.96M
P/E (TTM)
-2.0106
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IBIO last week (0615-0619)?
Weekly Report · 6d ago
Weekly Report: what happened at IBIO last week (0608-0612)?
Weekly Report · 06/15 10:00
Savara COO Robert Lutz to take CFO role as Lowrance steps down for health reasons
PUBT · 06/08 20:05
iBio Price Target Announced at $5.00/Share by Raymond James
Dow Jones · 06/08 18:01
Raymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5
Benzinga · 06/08 17:51
IBIO INC <IBIO.O>: RAYMOND JAMES INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $5
Reuters · 06/08 11:23
iBio initiated with an Outperform at Raymond James
TipRanks · 06/08 10:37
Weekly Report: what happened at IBIO last week (0601-0605)?
Weekly Report · 06/08 09:57
More
About IBIO
iBio, Inc. is a biotech company leveraging artificial intelligence and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with drug discovery platforms, it is creating a pipeline of antibody treatments to address significant unmet medical needs. Its proprietary StableHu technology is instrumental in this optimization process. StableHu is an AI- powered tool designed to predict a library of antibodies with fully human CDR variants based on an input antibody. It has a pipeline of pre-clinical programs with differentiated profiles and high potential impact, including IBIO-101, its second-generation anti-CD25 monoclonal antibody, a TROP-2 x CD3 bispecific antibody, an antibody that binds to a non-shed, non-glycosylated region of MUC16, an antibody that binds to an epitope on EGFRvIII without binding wildtype EGFR, and an anti-CCR8 antibody.

Webull offers Ibio Inc stock information, including NASDAQ: IBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IBIO stock methods without spending real money on the virtual paper trading platform.